 Use intravenous stilbestrol diphosphate patients prostatic carcinoma refractory conventional hormonal manipulation patient severe bone pain primary hormonal therapy vertebral collapse uremia ureteric obstruction intravenous stilbestrol diphosphate therapy urologist early marked improvement patients mobility pain reduction analgesic requirements single course treatment addition drug inexpensive free side effects cytotoxic therapy Accurate monitoring response possible serum prostate-specific antigen measurements therapy